Correlation Between Pfizer and Brookfield Asset

Can any of the company-specific risk be diversified away by investing in both Pfizer and Brookfield Asset at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Brookfield Asset into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc CDR and Brookfield Asset Management, you can compare the effects of market volatilities on Pfizer and Brookfield Asset and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Brookfield Asset. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Brookfield Asset.

Diversification Opportunities for Pfizer and Brookfield Asset

-0.87

Correlation Coefficient

Pfizer  Brookfield Asset

Pay attention - limited upside

The 3 months correlation between Pfizer and Brookfield is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc CDR and Brookfield Asset Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brookfield Asset Man and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc CDR are associated (or correlated) with Brookfield Asset. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brookfield Asset Man has no effect on the direction of Pfizer i.e., Pfizer and Brookfield Asset go up and down completely randomly.

Pair Corralation between Pfizer and Brookfield Asset

Assuming the 90 days trading horizon Pfizer Inc CDR is expected to under-perform the Brookfield Asset. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc CDR is 1.0 times less risky than Brookfield Asset. The stock trades about -0.06 of its potential returns per unit of risk. The Brookfield Asset Management is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  6,347  in Brookfield Asset Management on September 25, 2024 and sell it today you would earn a total of  1,521  from holding Brookfield Asset Management or generate 23.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	98.44%
Values	Daily Returns

Pfizer Inc CDR  vs.  Brookfield Asset Management

Pfizer Inc CDR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Pfizer is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Brookfield Asset Man

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Brookfield Asset Management are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating primary indicators, Brookfield Asset displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pfizer and Brookfield Asset

The main advantage of trading using opposite Pfizer and Brookfield Asset positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Brookfield Asset can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brookfield Asset will offset losses from the drop in Brookfield Asset's long position.

The idea behind Pfizer Inc CDR and Brookfield Asset Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.